BRIANA SHOWERS: Open Payments
NPI 1659009124 · KILLEEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 26 payments from 13 companies in 2025. Trend: 2023 $611 · 2024 $1,062 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 2 | $111 |
| Amgen Inc. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| PFIZER INC. | 2 | $54 |
| Medtronic, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Boston Scientific Corporation | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Stryker Corporation | 1 | $29 |
Products named: LOKELMA, REPATHA, LEQVIO, CAMZYOS, ELIQUIS, JARDIANCE, SAPIEN 3 Ultra RESILIA, FLOWTRIEVER.
Industry payments across TX — which companies pay providers there.
